Download PDF
Synfacts 2022; 18(11): 1261
DOI: 10.1055/s-0041-1738744
Innovative Drug Discovery and Development

A Candidate for Potential Treatment of Heart Failure with Preserved Ejection Fraction

Contributor(s):
Antonia F. Stepan (Roche)
,
Moritz Balkenhohl (BASF)
› Further Information
    Permissions and Reprints

Key words

myeloperoxidase - SAR study - heart failure


Publication History

Article published online:
18 October 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany